Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Related studies linked through entity extraction aliases.